🇺🇸 FDA
Patent

US 7348319

Nitric oxide-releasing amidine diazeniumdiolates, compositions and uses thereof and method of making same

granted A61KA61K31/13A61K31/655

Quick answer

US patent 7348319 (Nitric oxide-releasing amidine diazeniumdiolates, compositions and uses thereof and method of making same) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Mar 20 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue Mar 25 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 20 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
31
CPC classes
A61K, A61K31/13, A61K31/655, A61K38/00, A61P